Status:
COMPLETED
Effect of Aromatherapy Massage on Symptom Control
Lead Sponsor:
Sakarya University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although the incidence of colorectal cancers is high, it is often possible to treat it when diagnosed at an early stage. Although the treatment options vary according to many factors such as the type ...
Detailed Description
The population of the study will consist of patients who underwent colorectal cancer surgery between June 2021 and June 2022, and the sample of patients who meet the criteria for inclusion in the stud...
Eligibility Criteria
Inclusion
- Are over the age of 18
- Can understand and speak Turkish
- No mental or neurological disorders that may affect communication skills
- Not allergic to aromatic oils for aromatherapy massage group
- Patients undergoing curative surgery
- Not using antidepressant medication
- With an ASA score of 1-2-3
- Undergoing elective surgery
- Follow-up in the service after surgery
- No secondary cancer and recurrence surgery
- No contraindications for foot massage
- No major complications (bleeding, obstruction, anastomotic leak etc.) during the postoperative period
- Individuals who agree to participate in the study will be included.
Exclusion
- Under the age of 18
- Cannot understand and speak Turkish
- Having a mental or neurological condition that affects communication skills
- For aromatherapy massage group, allergic to aromatic oils
- Having had aromatherapy practice before
- Refusing to participate in research
- Stage IV patients
- Using antidepressant medication
- Emergency surgery applied
- ASA score of 4-5
- Permanent stoma opening
- Follow-up in intensive care after surgery
- Secondary cancer or surgery after relapse
- Major complications during the postoperative period
- Contraindicated for foot massage application (paraplegia, acute gout, foot ulcer, thrombosis, peripheral vascular disease, diffuse edema or lymphedema, acute foot injury or fracture)
- Having a pacemaker, uncontrolled hypertension, uncontrolled thyroid problems, epilepsy, bladder or kidney stones
- Patients with signs of active infection and fever will not be included in the study.
Key Trial Info
Start Date :
April 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04810299
Start Date
April 16 2021
End Date
March 23 2023
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sakarya University
Sakarya, Serdivan, Turkey (Türkiye), 54050